CBD for chronic pain: The science doesn’t match the marketing
CBD, a non-psychoactive component in cannabis, is emerging as a promising pharmaceutical agent to treat pain and other conditions. Unfortunately, few studies in humans have examined its effectiveness, and the cannabis industry’s profit motive is driving a wave of dubious claims about what CBD can do.
Content restricted. Requires subscription